Tag: Cellular Biomedicine Group

December 2, 2019

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
October 3, 2018

Cellular Biomedicine Group Obtained NCI Patent License

Cellular Biomedicine Group (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for...
March 16, 2018

Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin

Cellular Biomedicine Group (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies...
March 6, 2018

Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress

Cellular Biomedicine Group (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies...
January 19, 2018

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

Cellular Biomedicine Group (NASDAQ:CBMG), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its...